TG THERAPEUTICS, INC. (TGTX) Shareholders’ equity 2016–2025
TG THERAPEUTICS, INC. (TGTX) shareholders’ equity at each fiscal year-end, per SEC filings.
$648.0MFY2025 · since FY2016: $35.9M → $648.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $648.0M | +191.4% |
| FY2024 | $222.4M | +38.5% |
| FY2023 | $160.5M | +174.0% |
| FY2022 | $58.6M | -75.3% |
| FY2021 | $237.2M | -54.3% |
| FY2020 | $519.4M | +1244.9% |
| FY2019 | $38.6M | +60.7% |
| FY2018 | $24.0M | -64.1% |
| FY2017 | $67.0M | +86.8% |
| FY2016 | $35.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice